Literature DB >> 9438503

Delayed adverse reactions to nonionic monomeric contrast-enhanced media.

R Yasuda1, H Munechika.   

Abstract

RATIONALE AND
OBJECTIVES: A delayed adverse reaction is one occurring more than an hour after injection of contrast media. The frequency and symptoms of delayed adverse reaction to nonionic contrast media still are not well established. The purpose of the study is to clarify the frequency and symptoms of delayed adverse reactions using nonionic monomeric contrast media.
METHODS: Patients studied by computed tomography (CT) were the subject of the investigation. Delayed adverse reactions were compared between the group receiving CT without contrast injection and the group receiving contrast injection.
RESULTS: Delayed adverse reactions were noted in 293 of 2370 patients (12.4%) in the group with enhanced CT and in 93 of 907 patients (10.3%) in the group with unenhanced CT. The frequency of delayed adverse reaction to nonionic contrast media was 2.1% (12.4% - 10.3%; P = 0.094). None of the risk factors were related with the incidence of delayed adverse reaction. The most common delayed adverse reaction was a mild skin reaction, which occurred within 24 hours after injection of contrast media.
CONCLUSIONS: The frequency of delayed adverse reaction to nonionic monomeric contrast media was 2.1%; the most common reactions were itching and limited urticaria.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9438503     DOI: 10.1097/00004424-199801000-00001

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  9 in total

1.  Ataxia as a delayed reaction to contrast medium for an intravenous pyelography.

Authors:  Toru Watanabe
Journal:  Pediatr Nephrol       Date:  2003-01-11       Impact factor: 3.714

2.  CT method for visualization of the appendix using a fixed oral dosage of diatrizoate--clinical experience in 525 cases.

Authors:  Vincenzo Giuliano; Concetta Giuliano; Fabio Pinto; Mariano Scaglione
Journal:  Emerg Radiol       Date:  2005-06-03

3.  Fixed drug eruption induced by an iodinated non-ionic X-ray contrast medium: a practical approach to identify the causative agent and to prevent its recurrence.

Authors:  Ingrid Böhm; Jesus Medina; Pilar Prieto; Wolfgang Block; Hans H Schild
Journal:  Eur Radiol       Date:  2006-08-26       Impact factor: 5.315

4.  Late adverse reactions to intravascular iodine based contrast media: an update.

Authors:  Marie-France Bellin; Fulvio Stacul; Judith A W Webb; Henrik S Thomsen; Sameh K Morcos; Torsten Almén; Peter Aspelin; Olivier Clement; Gertraud Heinz-Peer; Peter Reimer; Aart van der Molen
Journal:  Eur Radiol       Date:  2011-07-16       Impact factor: 5.315

Review 5.  Iomeprol: a review of its use as a contrast medium.

Authors:  M Dooley; B Jarvis
Journal:  Drugs       Date:  2000-05       Impact factor: 9.546

6.  Monitoring non-immediate allergic reactions to iodine contrast media.

Authors:  M J Torres; C Mayorga; J A Cornejo-Garcia; S Lopez; P Chaves; C Rondon; T Fernandez; M Blanca
Journal:  Clin Exp Immunol       Date:  2008-03-12       Impact factor: 4.330

7.  Acute adverse drug reactions following cardiac catheterization: evidence-based guidance for providers and systems.

Authors:  Spencer W Trooboff; Alexander Iribarne
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

Review 8.  Current understanding of contrast media reactions and implications for clinical management.

Authors:  Marc J Meth; Howard I Maibach
Journal:  Drug Saf       Date:  2006       Impact factor: 5.228

Review 9.  Radiocontrast media hypersensitivity in the Asia Pacific region.

Authors:  Suh-Young Lee; Kyoung-Whan Lim; Yoon-Seok Chang
Journal:  Asia Pac Allergy       Date:  2014-04-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.